Skip to main content
. 2022 Oct 13;13:6043. doi: 10.1038/s41467-022-33768-x

Fig. 5. CD4 help, tumor antigen, and TGF-β-dependent establishment of TRM stem-like T cells in TDLN.

Fig. 5

a Experimental design for (b) to (e). Filled circle, control and empty circle, CD4 depleted. b Representative FACS profiles of total TDLN lymphocytes (left) and pre-gated Tcf-1+Pmel-1 T cells (right) are shown. c The percentage of Pmel-1 T cells in total TDLN CD8+ T cells are shown. d The percentage of Tcf-1+ cells in TDLN Pmel-1 T cells are shown. e The percentage of CD69+CD103+ (left), CD69+ (middle), and CD103+ (right) in Tcf-1+ Pmel-1 T cells are shown. For (c) to (e), n = 5/each. f Experimental design for (g) and h. Black, WT and red, Tgfbr2−/−. g Representative FACS profiles of donor OT-1 T cells isolated from B16-OVA draining LN (Left) and B16 draining LN (Right) are shown. h The percentage of CD69+CD103+ cells in stem-like OT-1 T cells (Upper) and the percentage of CD69+ cells in stem-like OT-1 T cells (Lower) are shown (n = 5/each). Data are presented as mean ± SEM. Each symbol represents the results from an individual recipient. N.S., not significant (p > 0.05), ****p < 0.0001 and indicated p values are calculated by Student t-test (ce) and Ordinary one-way ANOVA with multi-comparison posttest (h). Two-sided tests were used. Source data are provided as a Source data file.